Drug Research
Matrix-M, Saponin-Based Adjuvant Boosts Malarial Immunity
R21/Matrix-M happens to have a saponin-based adjuvant, Matrix-M, which goes on to enhance the immune response, thereby making it more viable and also durable.
It is well to be noted that the adjuvant stimulates the entry of the antigen-presenting cells...
Drug Research
Study Suggests Testicular Risk Highest With Neuro Disorder
A novel study by researchers at Uppsala University as well as its hospital has shown that men who happen to have a neurodevelopmental disorder like autism or ADHD have a higher risk of show this kind of link.
It has...
Drug Research
Pneumococcal Vaccines Aided By New Approach By Singapore
Numerous disease-causing bacteria like Streptococcus pneumoniae, happen to be encased in a sugar layer that is known as the capsular polysaccharide (CPS). This layer is often essential when it comes to infections.
In a discovery that can indeed be termed...
Drug Research
Upperton increases oral dosage form capabilities at its Nottingham HQ
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.
Part of Uppertonโs ยฃ15m investment program announced in January this year, the state-of-the-art...
Drug Research
Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery
Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that visualizes a comprehensive landscape of biological relationships, empowering researchers to gain a rapid understanding of disease biology and focus on critical evidence. Powered by Elsevierโs...
Drug Research
CPHI Japan: the rise of Chinese innovation the big macro story for APAC in 2023
Speaking at CPHI Japan 2023 (19-21), one keynote speaker โ Ian Haydock, Editor-In-Chief, Insights, Asia-Pacific at Citeline โ predicted that the continued rise of biopharma innovation in China is the big macro trend in the APAC region that could...
Drug Research
Drug Development Technology Leader ArisGlobal Completes Acquisition of Amplexor Life Sciences
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions with its end-to-end technology platform LifeSphereยฎ, announces the completion of its acquisition of Amplexor Life Sciences. This deal will deliver the most intelligent, connected,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















